Get the Stockscreener App
9.154
0.27%
0.026
Absci Corp stock is traded at $9.154, with a volume of 1.47M.
It is up +0.27% in the last 24 hours and up +10.97% over the past month.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.
See More
Previous Close:
$9.18
Open:
$9.19
24h Volume:
1.47M
Relative Volume:
0.30
Market Cap:
$1.57B
Revenue:
$1.84M
Net Income/Loss:
$-118.44M
P/E Ratio:
-11.04
EPS:
-0.8291
Net Cash Flow:
$-98.51M
1W Performance:
+2.16%
1M Performance:
+10.97%
6M Performance:
+246.05%
1Y Performance:
+214.16%
1-Day Range:
$8.84
$9.335
1-Week Range:
$8.64
$9.67
52-Week Range:
$2.24
$12.05
Absci Corp Stock (ABSI) Company Profile
Name
Absci Corp
Sector
Industry
Phone
(360) 949-1041
Address
18105 SE MILL PLAIN BLVD, VANCOUVER
Compare ABSI vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
9.13 | 1.58B | 1.84M | -118.44M | -98.51M | -0.8291 |
VRTX
Vertex Pharmaceuticals Inc
|
515.89 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.79 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
990.45 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
211.83 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.81 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-08-26 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-02-25 | Initiated | JP Morgan | Overweight |
| Jul-03-25 | Resumed | Morgan Stanley | Overweight |
| Jan-22-25 | Initiated | Needham | Buy |
| Oct-02-24 | Initiated | Guggenheim | Buy |
| Jul-03-24 | Initiated | Morgan Stanley | Overweight |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Overweight |
| May-04-23 | Initiated | H.C. Wainwright | Buy |
| Aug-12-22 | Downgrade | JP Morgan | Overweight → Underweight |
| Jul-18-22 | Initiated | Truist | Buy |
| Mar-02-22 | Resumed | Cowen | Market Perform |
| Feb-01-22 | Initiated | Berenberg | Buy |
| Nov-10-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Aug-16-21 | Initiated | BofA Securities | Neutral |
| Aug-16-21 | Initiated | Cowen | Market Perform |
| Aug-16-21 | Initiated | Credit Suisse | Outperform |
| Aug-16-21 | Initiated | Stifel | Hold |
View All
Absci Corp Stock (ABSI) Latest News
ABSI Stock Eyes Best Day Ever After Positive Hair Loss Drug Data, $100M Lilly-Backed Raise - Stocktwits
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen - marketbeat.com
Absci (NASDAQ:ABSI) Trading Down 4.4%Here's Why - marketbeat.com
Will Absci (NASDAQ:ABSI) Spend Its Cash Wisely? - Moomoo
Absci Corp (ABSI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Needham Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $11 - Moomoo
Absci Corporation (ABSI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Absci Corp. Earnings Call Highlights ABS-201 And Cash - The Globe and Mail
A Quick Look at Today's Ratings for Absci Corp(ABSI.US), With a Forecast Between $11 to $16 - Moomoo
Absci (ABSI) On Early ABS 201 Data And Lilly Deal That Could Support Its Valuation - Yahoo Finance
Absci (ABSI) Could Be 32% Undervalued Following ABS 201 Data And Earnings - simplywall.st
Absci (NASDAQ:ABSI) Shares Gap Down After Earnings Miss - marketbeat.com
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC - marketbeat.com
BTIG Research Reiterates Buy Rating for Absci (NASDAQ:ABSI) - MarketBeat
Absci (ABSI) Is Up 11.0% After Lilly Backs ABS-201 With US$40 Million Investment – Has The Bull Case Changed? - Yahoo Finance
TD Cowen Maintains Absci Corp(ABSI.US) With Buy Rating - Moomoo
ABSI SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Absci Q2 2026 Earnings Call Transcript - marketbeat.com
Absci Q2 Loss Narrows, Revenue Declines - Moomoo
Why is Absci stock tumbling today? - Investing.com
ABSI Looks 934.1% Overvalued on GF Value™ - GuruFocus
Absci Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS - marketbeat.com
Why is Absci stock tumbling today? By Investing.com - Investing.com Canada
Absci Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: Absci misses Q2 2026 estimates as stock falls after hours - Investing.com
Absci earnings missed by $0.02, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Absci shares tumble on earnings miss, weak revenue - Investing.com
Absci set to report earnings as partnership revenue surges By Investing.com - Investing.com UK
Absci shares tumble on earnings miss, weak revenue By Investing.com - Investing.com South Africa
Absci Corp 2026: Revenue $318K, EPS ($0.21) — 10-Q Summary - TradingView
Absci Corporation (NASDAQ: ABSI) boosts cash to $201M while net loss deepens - Stock Titan
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results - GlobeNewswire
ABSI Archives - 24/7 Wall St.
Absci set to report earnings as partnership revenue surges - Investing.com
ABSI Looks 881.3% Overvalued on GF Value™ - GuruFocus
Earnings To Watch: Absci Corp (ABSI) Q2 2026 -- GF Value Sees 92% Downside - GuruFocus
Absci Corp expected to post a loss of 20 cents a shareEarnings Preview - TradingView
Absci Corp (ABSI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Absci Corp (ABSI) Stock News Today - TradingKey
Earnings Preview: Absci Corp to Report Financial Results Post-market on August 11 - Moomoo
Absci (ABSI) to Announce Earnings on Tuesday - MarketBeat
H.C. Wainwright Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $16 - 富途牛牛
BTIG Maintains Absci Corp(ABSI.US) With Buy Rating, Maintains Target Price $13 - Moomoo
ABSI|Absci Corp|Price:7.920|Chg%:+0.140 - TradingKey
Absci Corp (ABSI) Valuation: PE, PB & Fair Value Analysis - TradingKey
A Small AI Company Just Took the Stage at One of the Biggest Events in Computing, and It Points to Where Drug Discovery Is Headed - marketscreener.com
ABSI|Absci Corp|Price:7.855|Chg%:+0.075 - TradingKey
Absci Corp (ABSI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Absci Corp Stock (ABSI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Absci Corp Stock (ABSI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pangalos Menelas N | Director |
May 13 '26 |
Buy |
5.36 |
37,453 |
200,748 |
232,308 |
| Busch Andreas | Chief Innovation Officer |
Mar 12 '26 |
Buy |
2.29 |
100,000 |
229,000 |
421,446 |
| Pangalos Menelas N | Director |
Feb 27 '26 |
Buy |
2.74 |
75,095 |
205,760 |
189,055 |
| McClain Sean | Chief Executive Officer |
Feb 23 '26 |
Option Exercise |
1.21 |
396,399 |
479,643 |
8,730,966 |
| McClain Sean | Chief Executive Officer |
Feb 02 '26 |
Sale |
2.99 |
26,761 |
80,015 |
8,334,567 |
| Jonasson Zachariah | CFO / CBO |
Feb 02 '26 |
Sale |
2.99 |
17,496 |
52,313 |
383,538 |
| VAN HOUTEN FRANS | Director |
Dec 05 '25 |
Buy |
3.72 |
40,000 |
148,800 |
63,320 |
| Pangalos Menelas N | Director |
Sep 22 '25 |
Buy |
2.66 |
95,785 |
254,788 |
113,960 |
| Bedrick Todd | SVP, CAO |
Sep 22 '25 |
Buy |
2.70 |
10,000 |
27,000 |
180,428 |
3.00%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):